Posted on

get rich marijuana seeds

How To Earn $1,000,000 Using Weed Seeds

The United States is working around the clock to legalize marijuana for medical use, with Canada making plans to follow the example of its big brother. In other words, the cannabis industry in these two huge markets will change for the better, creating many new opportunities for all those who plan on getting rich with weed seeds.

Legalization only means that the black market is a thing of the past, and the new market is ready for new players. If you never gave a thought to growing weed for a living, maybe it’s time for a change. Here’s how to earn $1,000,000 using weed seeds.

Be Prepared for a Big Change

If you’re already an avid weed expert, you should know that the time is right to change your ways. New markets demand new conditions. With the regular black market supply of customers eliminated from the equation, it’s time to turn your weed knowledge into a professional business.

Supplying both illegal and recreational black markets was one thing, but running a business is a whole new deal. Nowadays, it’s as much about growing weed as it is about being familiar with the regulations. In fact, the success of your weed business depends on your knowledge and compliance with the regulations.

Starting a professional weed seeds business requires resources, time, and effort. More importantly, it also requires a good deal of planning, as getting started is the hardest part.

So, financing your operations, getting started, and getting your products to the market, are the biggest three things that need your immediate attention. In addition, you’ll also need to worry about legalizing your operations.

Become a Professional

If you want to earn big bucks using weed seeds, you’ll need to understand the cannabis industry’s mechanisms. There is a long way to go between marketing your services to consumers and becoming a supplier. Building your network includes taking a great many steps and smart moves.

It’s all about finding the perfect balance between the growth and production aspects of your business. This balance allows you to determine how to approach your sales.

Marketing is everything today. Modern consumers have a very short attention span, and you need something wowing to grab their attention.

Marketing is one side of the coin while approaching consumers in the way they prefer is the other. Both efforts need to complement one another. It would be best if you were into weed cultivation as much as you are into marketing and improving your conversion rate.

Understand the Logistics

Being a professional weed grower and supplier is a complicated business. Since we’re talking about getting rich, growing your weed in a pot isn’t enough to launch you sky-high. While creating demand and growing enough to support that demand is one of the essential moves for your success, it’s how you distribute your products that matters in the end.

Transport and maintenance of your product expose you to a range of risks and problems. It’s how you deal with these problems that determine your ability to get rich further on. Since growing cannabis is an agricultural effort, there will be some association with pest management issues.

You’ll want to get these under control as failing to do so could endanger your entire operation. Then, there’s the cost of high energy consumption.

The weed seeds business requires certain conditions to provide the crops you need to achieve your business goal. Even more so, if you’re using an indoor facility as your main growing base.

Since monthly electricity bills can go over $30,000 or more, it would be wise to develop a production plan that allows you to mitigate your expenses. The best way to cut down on the expenses is to research the cost in different areas. Look for both labor and utility costs. Then there are other issues to worry about, such as environmental conditions, etc.

Reward Loyal Customers to Build a Following

Consumers love weed products, and the demand is ever-increasing. Therefore, your efforts to get rich should be based on supply and demand. The seller has the upper hand, but the competition is more than fierce.

Since the cannabis industry is one of the biggest growing ones, big companies are fighting for dominance. You’ll have to work hard to beat them, but you can do it by rewarding the most loyal customers and giving incentives to potential prospects to bring them into the fold.

See also  buy marijuana seeds in seattle

The best way to stand out from the rest of the crowd is by developing your own brand. Create your product philosophy and build your brand story around it.


If you want to turn your weed seeds into a real, professional business, you have to be prepared to make an investment that includes your resources, time, and effort. It’s a lot of hard work, but it’s absolutely doable. Launch your products and grow a following but make sure your business complies with the regulations to avoid troubles with the law.

How to Invest in Cannabis (Without Buying Cannabis Stocks)

Ancillary companies provide cannabis businesses with materials, technology and services without ever "touching" the plant.

Cannabis stocks have heated up in recent years. But investing in cannabis companies isn't as straightforward as your traditional blue-chip stocks.

Since cannabis is still illegal at the federal level, U.S. stock exchanges like the Nasdaq and New York Stock Exchange that are overseen by the Securities and Exchange Commission (SEC) – a federal agency – can't list marijuana stocks that "touch the plant." Instead, cannabis companies that go public often list on Canadian exchanges, making it difficult for typical brokerage accounts to trade.

Regardless, there are several ways to invest in cannabis without actually investing in cannabis companies. Ancillary firms provide cannabis businesses with materials, technology and services but don't deal in the plant itself. That allows them to profit off the growing pot business and stay listed on U.S. stock exchanges.

Read on as we look at several ways you can invest in cannabis without owning a pure "plant-touching" cannabis stock.

Data is as of July 1.


To consume cannabis, you have to put it in something. That's where accessory and hardware companies come in. These companies make vape and smoking hardware, as well as other devices and packaging for consumers.

KushCo Holdings (KSHB, $1.21) sells vaporizer hardware and technology, child-resistant and fully customized packaging solutions, as well as complementary solvents and natural products. (Note: KSHB trades "over-the-counter" and thus isn't subject to the same reporting requirements that Nasdaq- or NYSE-listed stocks are.) Greenlane Holdings (GNLN, $4.72) distributes vaporizers and smoking accessories across the world through dispensaries, smoke shops and through its own e-commerce stores. The company has partnerships to distribute well-known brands such as Marley Natural, K. Haring, Pax and Vibes.

Companies like Greenlane and KushCo manage to stay free and clear of federal drug paraphernalia laws since most smoking accessories can be used dually for cannabis or tobacco.


Cannabis is really nothing more than another cash crop, like coffee or sugar. While it's only a weed, the commercial cultivation of the plant is highly complex; it's difficult to get a plant to express the right properties to deliver the desired effect. In several states where growing seasons are short and/or unpredictable, cannabis is likely grown indoors, which requires greenhouses, growing containers, dirt, fertilizer and the like.

Several publicly listed companies provide these materials.

Engineering companies such as Urban-gro (UGRO, $9.20) design high-performance grow facilities across the horticulture sector, including cannabis. Agrify (AGFY, $12.96) provides vertical grow solutions, which maximize space, as well as sophisticated indoor environment regulation technology. Scotts Miracle-Gro (SMG, $191.02), one of the biggest sellers of lawn and garden products, offers its products and services for cannabis growers without being directly involved in the industry.


Once cannabis went legal in California, adult-beverage makers took note. Several of the largest brewery stocks quickly partnered up with Canadian cannabis brands to get a foothold in the industry.

Anheuser-Busch InBev (BUD, $71.51) partnered with Tilray (TLRY) to develop marijuana-infused drinks. Constellation Brands (STZ, $232.43), the beverage maker behind Corona made an ownership stake investment in Canopy Growth (CGC), and Molson Coors Beverage (TAP, $54.15) gained entry to the cannabis market through a joint venture with HEXO (HEXO).

Beer makers aren't the only ones who are hedging their future on cannabis drinks. Coffee Holding (JVA, $5.19), a nearly 50-year-old coffee company, bought a stake in privately owned CBD beverage firm The Jordre Well.


Cannabis is touted for its healing properties. In fact, it gained its foothold in the U.S. through state medical-use programs. Yet, clinical research on cannabis and its utility for medical conditions has been limited. What's more, the U.S. Food and Drug Administration has not approved a marketing application for cannabis for the treatment of any disease or condition.

The agency has, however, approved one cannabis-derived drug product and three synthetic cannabis-related drug products.

See also  omnita marijuana medical seeds

AbbVie (ABBV, $115.25) creates a synthetic form of marijuana, Marinol, used to treat nausea and the loss of appetite in patients suffering from AIDS. Jazz Pharmaceuticals (JAZZ, $180.40) announced in May that it had completed its $7.2 billion acquisition of GW Pharmaceuticals (GWPH), which makes the cannabis-derived seizure treatment Epidolex. The premium price for GW demonstrates that pharmaceutical companies recognize the value and future potential of cannabinoid-based medicines.

Real Estate

Real estate has long been a way for the rich and connected to grow their wealth. Investors can get a piece of the action by investing in holding real estate investment trusts (REITs). Cannabis REITs were been the best-performing property sector for the second year in a row in 2020, soaring more than 150% despite the ongoing pandemic.

Check out companies such as Power REIT (PW, $40.27), which owns real estate assets related to controlled environmental agriculture, including greenhouse cannabis cultivation, and Innovative Industrial Properties (IIPR, $193.59), which focuses exclusively on the acquisition, ownership, and management of specialized properties leased to medical-use cannabis facilities. Together, these two account for nearly $5 billion in market value.

Investors who want to take advantage of the growth in the cannabis industry don't have to only choose traditional marijuana stocks. Adding companies that service the sector can complement cannabis investing or be a standalone strategy. After all, as more states flip from medical to rec, ancillary companies that support cannabis companies will continue to see major growth.

New CBD-rich cannabis seeds

In recent years the numerous scientific studies that have come to light demonstrating the medicinal properties of CBD have led to a marked increase in the demand, not just for CBD-rich cannabis varieties, but also for food and cosmetic products high in CBD.

As a result, cannabis breeders and geneticists have been working to stabilise their hybrids, maximising the cannabinoid content in their varieties, and each year more new varieties with higher and higher CBD contents are released on the market.

As an example of this evolution, in this article we will talk about several of the new generation of CBD-rich cultivars, all recent additions to the Alchimia seed catalogue. These are varieties specially developed to achieve as high a level of CBD as possible in the majority of the offspring, with almost no psychoactive effect, but with a high therapeutic potential making them ideal for the treatment of diverse ailments such as depression, anxiety, ADHD, anorexia, epilepsy, autism, and many other conditions.

Dinamed CBD from Dinafem

One of Spain’s best-known seed banks, Dinafem have developed their first 100% therapeutic variety, Dinamed CBD. Based on the Reggae Seeds’ strain Dancehall, the team of breeders at Dinafem have managed to isolate and stabilise individuals with the highest CBD content, achieving a spectacular THC/CBD ratio of 1:25 in 90% of plants.

To develop this strain, Dinafem first grew out 2,000 Dancehall plants from regular seeds, carefully selecting only two females and one male, which were crossed with each other. The next step was to germinate 500 of the seeds from this cross, eventually choosing one example particularly high in CBD and notably low in THC, which was dubbed Pure CBD 4. Dinamed CBD is the final result of reversing this Pure CBD 4 plant and pollinating it with itself, producing a feminised strain with a THC content of 0.5-1% and a CBD of 10-14%.

Dinamed CBD from Dinafem, up to 14% CBD

It’s a well-balanced hybrid (60% Sativa/40% Indica) with a good production of up to 500g per square metre, suitable for both outdoor and indoor cultivation. It flowers quickly, being ready to harvest after 60 days indoors, and in the second week of September when grown in outdoor gardens, where it’s capable of producing up to 1000g per plant. It’s structure is mainly Sativa, with narrow leaves and good development of lateral branches. It’s a perfect cultivar for growing in SCROG (Screen of Green) setups.
The flavour is orange, citric, sweet and fruity, while the psychoactive effect is barely perceptible, with a slight sensation of relaxation, leaving users able to deal easily with almost any type of normal daily task.

Candida by Medical Marijuana Genetics

Candida (CD1) is the flagship medical strain of new British seed bank Medical Marijuana Genetics. It’s a Sativa-dominant hybrid developed by crossing the renowned medical strains AC/DC and Harlequin, both boasting a high CBD content with hardly any THC. AC/DC is a Northern Californian clone-only selection of Resin Seeds’ Cannatonic with a THC/CBD ratio of 1:20 and up to 19% CBD. Harlequin is a 4-way hybrid (using genetics from Colombia, Thailand, Switzerland and Nepal) with a THC/CBD ratio of 2:5 and up to 13% CBD and 5% THC.

See also  legal to have marijuana seeds new mexico

Slender bud of Medical Marijuana Genetics Candida (CD1)

Fruit of this cross, Candida is a hybrid with an great number of therapeutic applications in the medical field but with no psychoactive effects: it’s THC/CBD ratio of 1:20 (0.5% THC to 11-20% CBD) is ideal for treating a wide range of symptoms and ailments, without leaving users feeling ‘high’, perfect for users unfamiliar with THC-rich cannabis and for combining daytime consumption with normal daily functions.

Cultivated indoors under lights, Candida flowers in around 9 weeks, producing approximately 500g per square metre. It’s a vigorous, resistant and easy plant to grow outdoors, where it’s ready to harvest in early October and needs no special care to get big yields. As with Dinamed CBD, it’s effect is barely perceptible given the extremely low content of THC, the cannabinoid that’s responsible for the psychoactive ‘high’ of cannabis.

CBD Therapy by CBD Crew

For 4 years, the team of breeders at CBD Crew has been working to develop a cannabis strain for medicinal users with the lowest possible THC content and maximum CBD. After this long process, they have released CBD Therapy, one of the first varieties to reach a 1:20 ratio in some specimens, with a CBD content of up to 10% but only 0.5% THC.

CBD Therapy by CBD Crew, with a THC/CBD ratio of up to 1:20

In CBD Therapy, however, this feature is not as stable as in the other two varieties we previously mentioned. The THC/CBD ratio can vary from 1:2 to 1:20, so you will find variations in effects depending on the plant being consumed. Far from being a negative factor, this genetic variability offers the opportunity for users to test a crop of plants with different properties and select the plant whose effects best suit their medical needs. They can then keep this mother plant to ensure a reliable and consistent supply of clones with the perfect chemotype for the desired therapeutic effect.

CBD Therapy’s flowering period is rapid, between 8 and 9 weeks, and it yields well, giving about 500g per m2, making it an excellent choice for medical users. It’s adapted both to indoor, greenhouse and outdoor cultivation, where it is usually harvested in October. It’s flavour is predominantly fruity, with sugary notes and earthy nuances.

Entourage effect and seeds with THC/CBD ratio 1: 1

There are increasing varieties of cannabis rich in CBD

In recent years, you may have heard the term “entourage effect” (although Dr Lester Grinspoon prefers the term “therapeutic ensemble”). This refers to the synergy created by the different cannabinoids, terpenes, flavonoids, etc. contained within the glandular trichomes of cannabis. According to numerous (and prestigious) researchers, the medicinal effects of the various compounds present in cannabis are enhanced by acting in synergy with each other, with many conditions benefitting greatly from a treatment using varieties with a more balanced THC/CBD ratio, as opposed to CBD only.

As many users of medical cannabis don’t mind (indeed, many enjoy) the feeling of mild and totally controlable intoxication, many varieties with a THC/CBD ratio of 1:1 have been developed and released onto the market. These strains usually contain only moderate amounts of each cannabinoid, offering a balanced and mild psychoactivity induced by the THC but modulated and attenuated by the CBD, giving a pleasant effect that even so, can’t be compared in potency with the THC-rich ‘recreational’ cultivars.

Beautiful specimen of Spicy CBD from Philosopher Seeds

Varieties such as Spicy CBD from Philosopher Seeds (8% THC and CBD), CBD Critical Mass from CBD Crew (5% THC, 5/8% CBD), CBD Chronic from Serious Seeds (5% THC and CBD) or Hiydrow (HY-1) by Medical Marijuana Genetics (8.5% THC and 12% CBD) offer a much more balanced content than the varieties mentioned above, although their CBD content may not be as high.

It’s obvious to see that medical cannabis breeding is experiencing a boom time, with new plants offering better characteristics constantly being discovered, developed and released to bring the relief that so many patients desperately seek. In addition, the development of these varieties will undoubtedly lead to more effective derivatives being developed in the future, thus improving the already extensive range of CBD products available on the market today.